Tylenol Sinus Severe Tablet, Coated
NDC Package 67751-239-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Tylenol Sinus Severe (acetaminophen, guaifenesin, and phenylephrine hydrochloride) tablets is do not take more than directed (see overdose warning) adults and children 12 years and overtake 2 caplets every 4 hoursswallow whole; do not crush, chew or dissolvedo not take more than 10 caplets in 24 hourschildren under 12 yearsask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-239 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
67751-239-01
Package Description
1 POUCH in 1 CARTON / 2 TABLET, COATED in 1 POUCH
Product Code
11-Digit Billing Format
67751023901
RxNorm Crosswalk
  • RxCUI: 1243679 - acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1243679 - acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1243679 - APAP 325 MG / GG 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1243679 - APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Tylenol Sinus Severe
Non-Proprietary Name
Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride
Substance Name
Acetaminophen; Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Do not take more than directed (see overdose warning) adults and children 12 years and overtake 2 caplets every 4 hoursswallow whole; do not crush, chew or dissolvedo not take more than 10 caplets in 24 hourschildren under 12 yearsask a doctor

Regulatory & Marketing

Labeler Name
Navajo Manufacturing Company Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-19-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67751-239). Click a package code to view its specific billing and regulatory data.

2 POUCH in 1 CARTON / 2 TABLET, COATED in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67751-239-01 identifies a specific commercial package of 1 pouch in 1 carton / 2 tablet, coated in 1 pouch of Tylenol Sinus Severe, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This tablet, coated is formulated for oral use and contains acetaminophen; guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on February 19, 2025. The current certification is valid through December 31, 2026.

How is this Navajo Manufacturing Company Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751023901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67751-239-01
11-Digit CMS (5-4-2)
67751-0239-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.